Literature DB >> 3018039

Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis.

W M Johnson, H Lior.   

Abstract

Complete toxigenicity studies were performed on 341 strains of Campylobacter spp., including 23 nonhuman isolates. Toxin profiles based on both cytotonic and cytotoxic factors were determined after analyzing responses in Vero, HeLa, CHO and Y-1 cells. Suckling mouse assays were consistently negative for all culture filtrates tested. Toxin-producing strains were frequently encountered among both the human and nonhuman strains of Campylobacter jejuni, C. coli, and C. laridis investigated. Strains isolated from outbreaks demonstrated parallels in serotype, biotype, and toxigenicity profile, although no clear association could be demonstrated. Biphasic culture conditions conducive to the production of both toxic factors were delineated for the propagation of test Campylobacter strains. Cytotonic effects of Campylobacter culture filtrates were determined in Vero and CHO cells, and cyclic AMP accumulation in cells exposed to these culture filtrates was compared with that in cells exposed to reference toxigenic strains of Vibrio cholerae and Escherichia coli. Partial neutralization of C. jejuni enterotoxin was demonstrated by using antitoxins to cholera toxin and E. coli heat-labile enterotoxin. No neutralization of C. jejuni cytotoxin could be achieved by using antitoxins to either Clostridium difficile cytotoxin or E. coli Verotoxin (0157:H7).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018039      PMCID: PMC268889          DOI: 10.1128/jcm.24.2.275-281.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Pathogenic mechanisms of a non-agglutinable Vibrio cholerae strain: demonstration of invasive and enterotoxigenic properties.

Authors:  R M Robins-Browne; C S Still; M Isaäcson; H J Koornhof; P C Appelbaum; J N Scragg
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Serum antibodies to heat-labile enterotoxin of Campylobacter jejuni.

Authors:  G M Ruiz-Palacios; Y López-Vidal; J Torres; N Torres
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

4.  The virulence of clinical and environmental isolates of Campylobacter jejuni.

Authors:  D G Newell; H McBride; F Saunders; Y Dehele; A D Pearson
Journal:  J Hyg (Lond)       Date:  1985-02

5.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

6.  Cytotonic enterotoxins and cytotoxic factors produced by Salmonella enteritidis and Salmonella typhimurium.

Authors:  S B Baloda; A Faris; K Krovacek; T Wadström
Journal:  Toxicon       Date:  1983       Impact factor: 3.033

7.  Experimental Toxigenicity of NAG Vibrios.

Authors:  M Draskovicová; J Karolcek
Journal:  Zentralbl Bakteriol Orig A       Date:  1977-02

8.  New, extended biotyping scheme for Campylobacter jejuni, Campylobacter coli, and "Campylobacter laridis".

Authors:  H Lior
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

9.  Properties of crude Campylobacter jejuni heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations.

Authors:  F A Klipstein; R F Engert; H Short; E A Schenk
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

View more
  21 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

3.  Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni.

Authors:  S Mahajan; F G Rodgers
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

Authors:  E Sjögren; G Ruiz-Palacios; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

5.  In vitro model for Campylobacter pylori adherence properties.

Authors:  V Neman-Simha; F Mégraud
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

6.  Virulence of Campylobacter jejuni for chicken embryos is associated with decreased bloodstream clearance and resistance to phagocytosis.

Authors:  L H Field; J L Underwood; S M Payne; L J Berry
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

7.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  Physical map of Campylobacter jejuni TGH9011 and localization of 10 genetic markers by use of pulsed-field gel electrophoresis.

Authors:  N W Kim; H Bingham; R Khawaja; H Louie; E Hani; K Neote; V L Chan
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

9.  Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin.

Authors:  M John Albert; Shilpa Haridas; Ben Adler
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

10.  Incidence of toxigenic Campylobacter strains in South Africa.

Authors:  H E Bok; A S Greeff; H H Crewe-Brown
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.